Stock listing
4574 Stock Price, News, Filings & Events — Taiko Pharmaceutical Co., Ltd.
Selected listing: 4574 · TSE · JPY · JP
This page tracks Taiko Pharmaceutical Co., Ltd.'s 4574:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4574:TSE. 4574:TSE is the stock-level entry point for investors researching Taiko Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Taiko Pharmaceutical Co., Ltd. is a publicly traded company in Japan, listed under the ticker 4574. The company has a market capitalization of approximately 79.77 million USD. Taiko Pharmaceutical focuses on developing and providing innovative healthcare solutions.

- Ticker
- 4574:TSE
- Asset type
- Stock
- Market cap
- $80.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSE
- Currency
- JPY
Taiko Pharmaceutical Co., Ltd. 4574:TSE stock context
This page tracks Taiko Pharmaceutical Co., Ltd.'s 4574:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4574:TSE. 4574:TSE is the stock-level entry point for investors researching Taiko Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Taiko Pharmaceutical Co., Ltd. is a publicly traded company in Japan, listed under the ticker 4574. The company has a market capitalization of approximately 79.77 million USD. Taiko Pharmaceutical focuses on developing and providing innovative healthcare solutions.
Research Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. investor report
Review AI stock analysis and investor report context for 4574:TSE.
Taiko Pharmaceutical Co., Ltd. company profile
View the public company page for Taiko Pharmaceutical Co., Ltd. on 6ix.
Taiko Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Taiko Pharmaceutical Co., Ltd..
Taiko Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Taiko Pharmaceutical Co., Ltd..